For Clinical benefit rate
Debate : Tumor shrinkage (objective response) or clinical benefit rate : Which is the appropriate efficacy endpoint for Metronomic therapy?
Speaker :
Dr. Randeep Singh, Delhi
For Clinical benefit rate
Speaker :
Dr. Randeep Singh, Delhi